WealthPLAN Partners LLC Invests $1.55 Million in Veralto Co. (NYSE:VLTO)

WealthPLAN Partners LLC purchased a new position in shares of Veralto Co. (NYSE:VLTO - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 13,812 shares of the company's stock, valued at approximately $1,545,000.

A number of other large investors also recently modified their holdings of VLTO. Ashton Thomas Securities LLC bought a new position in shares of Veralto during the 3rd quarter worth approximately $25,000. Goodman Advisory Group LLC acquired a new stake in Veralto during the 2nd quarter valued at $26,000. Fairscale Capital LLC bought a new position in Veralto during the second quarter worth $30,000. Raleigh Capital Management Inc. increased its holdings in shares of Veralto by 692.3% in the third quarter. Raleigh Capital Management Inc. now owns 309 shares of the company's stock valued at $35,000 after purchasing an additional 270 shares during the last quarter. Finally, LRI Investments LLC bought a new position in shares of Veralto in the first quarter valued at about $30,000. 91.28% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Veralto

In other news, CEO Jennifer Honeycutt sold 13,191 shares of the stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $111.98, for a total value of $1,477,128.18. Following the completion of the sale, the chief executive officer now owns 138,546 shares of the company's stock, valued at approximately $15,514,381.08. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, SVP Surekha Trivedi sold 753 shares of the company's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $111.10, for a total transaction of $83,658.30. Following the transaction, the senior vice president now directly owns 11,918 shares of the company's stock, valued at $1,324,089.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jennifer Honeycutt sold 13,191 shares of Veralto stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $111.98, for a total transaction of $1,477,128.18. Following the transaction, the chief executive officer now owns 138,546 shares of the company's stock, valued at $15,514,381.08. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 36,038 shares of company stock worth $3,989,693 over the last three months. Company insiders own 0.31% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on VLTO. Stifel Nicolaus increased their price target on shares of Veralto from $117.00 to $119.00 and gave the company a "buy" rating in a report on Wednesday, October 16th. Royal Bank of Canada increased their price objective on Veralto from $108.00 to $111.00 and gave the stock a "sector perform" rating in a research report on Friday, October 25th. TD Cowen upped their price target on shares of Veralto from $95.00 to $100.00 and gave the company a "hold" rating in a research note on Tuesday, July 30th. Robert W. Baird raised their price target on shares of Veralto from $98.00 to $112.00 and gave the stock a "neutral" rating in a research report on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Veralto from $100.00 to $109.00 and gave the stock a "hold" rating in a research report on Monday, July 29th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Veralto has a consensus rating of "Hold" and a consensus target price of $108.27.

Veralto Price Performance

NYSE:VLTO traded up $0.31 during trading hours on Tuesday, hitting $104.70. The company's stock had a trading volume of 185,417 shares, compared to its average volume of 1,535,220. Veralto Co. has a twelve month low of $70.06 and a twelve month high of $115.00. The company has a debt-to-equity ratio of 1.35, a current ratio of 2.13 and a quick ratio of 1.87. The stock has a fifty day simple moving average of $109.08 and a 200-day simple moving average of $103.93. The company has a market capitalization of $25.89 billion and a P/E ratio of 32.22.

Veralto (NYSE:VLTO - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $0.89 EPS for the quarter, beating analysts' consensus estimates of $0.85 by $0.04. The company had revenue of $1.31 billion during the quarter, compared to analysts' expectations of $1.30 billion. Veralto had a return on equity of 52.85% and a net margin of 15.69%. Veralto's revenue was up 4.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.75 EPS. On average, analysts anticipate that Veralto Co. will post 3.48 EPS for the current fiscal year.

Veralto Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Friday, September 27th were paid a $0.09 dividend. The ex-dividend date was Friday, September 27th. This represents a $0.36 annualized dividend and a dividend yield of 0.34%. Veralto's dividend payout ratio is 11.11%.

Veralto Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.